Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Rapid and Sustained Engraftment of a Single Allogeneic Ex-Vivo Expanded Cord Blood Unit (CBU) After Reduced Intensity Conditioning (RIC) in Adults. Preliminary Results of a Prospective Trial

Noel Milpied, MD, Bernard Dazey, MD, Zoran Ivanovic, MD PHD, Pascale Duchez, Stephane Vigouroux, MD, Reza Tabrizi, MD, Arnaud Pigneux, MD, PhD, Marie-Sarah Dilhuydy, MD, Krimo Bouabdallah, MD, Thibaut Leguay, MD, Mathieu Sauvezie, Xavier Lafarge, MD, Gerald Marit, MD, PhD, Jean-Michel Boiron, MD, PhD

Blood (2011) 118 (21): 486.

https://doi.org/10.1182/blood.V118.21.486.486

Published: 2011

Journal Articles

The Prophylactic Use of G-CSF During Induction and Consolidation of Adults with Acute Lymphoblastic Leukemia Is Associated with Reduced Risk of Relapse and Improved Leukemia-Free Survival. A Joint Analysis of Five Randomized Trials on Behalf of the European Working Group for Adult ALL (EWALL)

Sebastian Giebel, MD, Xavier Thomas, MD, PhD, Helene Hallbook, MD, Klaus Geissler, MD, Jean-Michel Boiron, MD, PhD, Françoise Huguet, MD, Bengt Smedmyr, MD, PhD, Elisabeth Koller, MD, Andrzej Hellmann, MD, Jerzy Holowiecki, MD

Blood (2010) 116 (21): 2130.

https://doi.org/10.1182/blood.V116.21.2130.2130

Published: 2010

Journal Articles

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Andrea Toma, Marie-Lorraine Balère-Appert, Jean-Michel Boiron, MD, Pierre Bordigoni, Pr, Gerard Socie, MD, PhD, Jean-Paul Vernant, Pr, Marc Renaud, MD, Noel Milpied, MD, PhD, Mauricette Michallet, MD, PhD, Eric Deconinck, Pr, Denis Guyotat, MD, PhD, Frederic Garban, MD, Anne Sirvent, MD, Nathalie Contentin, MD, Didier Blaise, Pr, Evelyne Marry, Agnes Buzyn, Pr

Blood (2009) 114 (22): 873.

https://doi.org/10.1182/blood.V114.22.873.873

Published: 2009

Journal Articles

Ex-Vivo Expanded Peripheral Blood Stem Cells (EVEC) Compared with Un Manipulated Peripheral Blood Stem Cells (PBSC) Autologous Transplantation for Multiple Myeloma: A Pair Match Analysis.

Noel-Jean Milpied, MD, Gerald Marit, Bernard Dazey, Jean-Michel Boiron, MD, PhD, Zoran Ivanovic, Carine Foucaud, Fontanet Bijou, Krimo Bouabdallah, MD, Anna Schmitt, Mathieu Sauvezie, Christian Cailliot, MD, Josy Reiffers

Blood (2009) 114 (22): 502.

https://doi.org/10.1182/blood.V114.22.502.502

Published: 2009

Journal Articles

Functional and Phenotypic Characterizations of Granulocyte-Colony Stimulating Factors Mobilzed CD34+ Cells.

Fontanet Bijou, Muhamed Hammoud, Marija Vlaski, Pascale Duchez, Noel-Jean Milpied, MD, Xavier Lafarge, Jean Chevaleyre, Bouzgarrou Ridha, Bernard Dazey, Jean-Michel Boiron, MD, PhD, Zoran Ivanovic

Blood (2009) 114 (22): 2143.

https://doi.org/10.1182/blood.V114.22.2143.2143

Published: 2009

Journal Articles

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission in Mantle Cell Lymphoma: Long Term Follow up of a Randomized Trial of the

Martin H. Dreyling, MD, Eva Hoster, PhD, Achiel Van Hoof, Bernd Metzner, Christian Gisselbrecht, Michael Pfreundschuh, MD, PhD, Marcel Reiser, Lorenz H. Truemper, MD, PhD, Hjalmar Steinhauer, Jean-Michel Boiron, MD, PhD, Marc Boogaerts, MD, PhD, Vittorio Silingardi, J.C. Kluin- Nelemans, MD, PhD, Michael Unterhalt, Wolfgang Hiddemann

Blood (2008) 112 (11): 769.

https://doi.org/10.1182/blood.V112.11.769.769

Published: 2008

Journal Articles

Impact of the Use of Thalidomide, Lenalidomide, or Bortezomib, Compared to“standard Chemotherapy”, as “salvage” Before Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC-AT), for Relapsed Multiple Myeloma

Anna Schmitt, Reza Tabrizi, MD, Stephane Vigouroux, Mathieu Sauvezie, Carine Foucaud, Krimo Bouabdallah, marie-Sarah Dilhuydy, Arnaud Pigneux, MD, PhD, Thibaut Leguay, didier-Innocent Adiko, Jean-Michel Boiron, MD, PhD, Gerald Marit, Noel-Jean Milpied, PhD

Blood (2008) 112 (11): 4310.

https://doi.org/10.1182/blood.V112.11.4310.4310

Published: 2008

Journal Articles

Ciclosporine and Metotrexate Reduce the Risk of High Grade Acute Gvhd after Busulfan, Fludarabine and Anti-Thymocyte Globulin conditioning Regimen in Comparison with Cyclosporine Alone

Reza Tabrizi, Stephane Vigouroux, Arnaud Pigneux, Thibaut Leguay, Krimo Bouabdallah, Marie-Sarah Dilhuydy, Carine Foucaud, Pierre-Yves Dumas, Axelle Lascaux, Mohamed Zarrouk, Jean-Michel Boiron, MD, PhD, Fontanet Bijou, Pascal Turlure, Cyril Melot, Gerald Marit, Noel Milpied

Blood (2008) 112 (11): 4331.

https://doi.org/10.1182/blood.V112.11.4331.4331

Published: 2008

Journal Articles

Updated Analysis of Allogeneic HSCT after RIC for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Mohamad Mohty, MD, PhD, Franck E. Nicolini, MD, PhD, Jean-Michel Boiron, MD, Hélène Espérou, MD, Michel Attal, MD, PhD, Noel Milpied, MD, Bernard Lioure, MD, Pierre Bordigoni, MD, Ibrahim Yackoub-Agha, MD, PhD, Jean-Henri Bourhis, MD, PhD, Bernard Rio, MD, Eric Deconninck, MD, Marc Renaud, MD, Mohamad Sobh, PhD, Nicole Raus, Didier Blaise, MD

Blood (2007) 110 (11): 1085.

https://doi.org/10.1182/blood.V110.11.1085.1085

Published: 2007

Journal Articles

Outcome of Treatment after First Relapse in Adults Patients with Acute Lymphoblastic Leukemia (ALL) Initially Treated by the LALA-94 Trial.

Emmanuelle Tavernier, MD, Jean-Michel Boiron, MD, Francoise Huguet, MD, Kenneth Francis Bradstock, MD, Norbert Vey, MD, Tibor Kovacsovics, MD, Andre Delannoy, MD, Nathalie Fegueux, MD, Pierre Fenaux, MD, Aspasia Stamatoullas, MD, Olivier Tournilhac, MD, Agnes Buzyn, MD, Oumedaly Reman, MD, Christiane Charrin, MD, Claude Boucheix, MD, Jean Gabert, MD, Veronique Lheritier, CRA, Jean-Paul Vernant, MD, Xavier Thomas, MD

Blood (2006) 108 (11): 1876.

https://doi.org/10.1182/blood.V108.11.1876.1876

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation with Reduced Intensity Conditionning Regimen (RIC) for Adult Patients with AML: Same Results in Secondary and De Novo AML.

Noel-Jean Milpied, MD, Reza Tabrizi, MD, Thierry Guillaume, MD, Patrice Chevallier, MD, Arnaud Pigneux, MD, Jean Michel Boiron, MD, Philippe Moreau, MD, Beatrice Mahe, MD, Thibaut Leguay, MD, Krimo Bouabdallah, MD, Nadine Morineau, MD, Jacques Delaunay, MD, Cyril Melot, Beatrice Saulquin, Gerald Marit, MD, Jean Luc Harousseau, MD

Blood (2006) 108 (11): 3015.

https://doi.org/10.1182/blood.V108.11.3015.3015

Published: 2006

Journal Articles

Updated Analysis of Hematopoietic Stem Cell Transplantations after Reduced Intensity Conditioning Regimen (RIC HSCT) for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Thomas Prebet, MD, Mohamad Mohty, MD, PhD, Jean Michel Boiron, MD, Hélène Esperou, MD, Noel Milpied, MD, Nathalie Dhédin, MD, Didier Blaise, MD

Blood (2005) 106 (11): 45.

https://doi.org/10.1182/blood.V106.11.45.45

Published: 2005

Journal Articles

Low Progression-Free Survival for High-Risk Patients Treated with Reduced-Intensity Conditioning Regimen Allogeneic Stem Cell Transplantations with Volunteer Unrelated Donors.

Reza Tabrizi, MD, Fontanet Bijou, MD, Krimo Bouabdallah, MD, Thibaut Leguay, MD, Gerald Marit, MD, Arnaud Pigneux, MD, Aurelie Gomez, MD, Francis Belloc, Xavier Lafarge, Jean-Michel Boiron, MD, PhD

Blood (2005) 106 (11): 5432.

https://doi.org/10.1182/blood.V106.11.5432.5432

Published: 2005

Journal Articles

Impact of Hematopoietic Stem Cell (HSC) Recruitment and Graft Composition on Transplant Outcome after Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Study of the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Thomas Prebet, MD, Quoc-Hung Le, MD, Jean-Michel Boiron, MD, Didier Blaise, MD, Anne Huynh, MD, Ibrahim Yakoub-Agha, MD, Hélène Esperou, MD, Fréderic Garban, MD, PhD, Jean Henri Bourhis, MD, Mauricette Michallet, MD, PhD

Blood (2005) 106 (11): 1146.

https://doi.org/10.1182/blood.V106.11.1146.1146

Published: 2005

Journal Articles

Usefulness of Recombinant Human Erythropoietin during Induction-Consolidation Chemotherapy for Chronic Hematological Lymphoid Malignancies: Improving Stem Cell Harvest and Reducing Blood-Product Support for Patients Receiving Autologous Stem-Cell Transplantation.

Fontanet D. Bijou, MD, Reza Tabrizi, MD, Thibaut Legay, MD, Cyril Melot, Krimo Bouabdallah, MD, Arnaud Pigneux, MD, Jean-Michel Boiron, MD, Gerald Marit, MD

Blood (2005) 106 (11): 5293.

https://doi.org/10.1182/blood.V106.11.5293.5293

Published: 2005

Journal Articles

Dendritic Cells Recovery and Chimerism after Reduced Intensity Hematopoietic Stem Cell Transplantation.

Reza Tabrizi, MD, Francis Belloc, PhD, Xavier Lafarge, Virginie Perreau, Krimo Bouabdallah, MD, Gerald Marit, MD, Fontanet Bijou, MD, Thibaut Leguay, MD, Francis Lacombe, Arnaud Pigneux, MD, Cyril Melot, François Comeau, Jean-Michel Boiron, MD, PhD

Blood (2005) 106 (11): 5341.

https://doi.org/10.1182/blood.V106.11.5341.5341

Published: 2005

Journal Articles

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free Survival in Mantle Cell Lymphoma - Long Term Follow up of a Prospective Randomized Trial of the European MCL Network .

Martin H. Dreyling, MD, PhD, Georg Lenz, MD, Eva Schiegnitz, MSc, Achiel van Hoof, MD, Christian Gisselbrecht, MD, PhD, Michael Pfreundschuh, MD, PhD, Bernd Metzner, MD, Lorenz H. Truemper, MD, PhD, Marcel Reiser, MD, Hjalmar B. Steinhauer, MD, PhD, Jean-Michel Boiron, MD, PhD, Marc A. Boogaerts, MD, PhD, Ali Aldaoud, MD, Vittorio Silingardi, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Joerg Hasford, MD, PhD, Reza Parwaresch, MD, PhD, Unterhalt Michael, MD, PhD, Hiddemann Wolfgang, MD, PhD

Blood (2004) 104 (11): 7.

https://doi.org/10.1182/blood.V104.11.7.7

Published: 2004

NARROW

Rapid and Sustained Engraftment of a Single Allogeneic Ex-Vivo Expanded Cord Blood Unit (CBU) After Reduced Intensity Conditioning (RIC) in Adults. Preliminary Results of a Prospective Trial

The Prophylactic Use of G-CSF During Induction and Consolidation of Adults with Acute Lymphoblastic Leukemia Is Associated with Reduced Risk of Relapse and Improved Leukemia-Free Survival. A Joint Analysis of Five Randomized Trials on Behalf of the European Working Group for Adult ALL (EWALL)

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Ex-Vivo Expanded Peripheral Blood Stem Cells (EVEC) Compared with Un Manipulated Peripheral Blood Stem Cells (PBSC) Autologous Transplantation for Multiple Myeloma: A Pair Match Analysis.

Functional and Phenotypic Characterizations of Granulocyte-Colony Stimulating Factors Mobilzed CD34+ Cells.

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission in Mantle Cell Lymphoma: Long Term Follow up of a Randomized Trial of the

Impact of the Use of Thalidomide, Lenalidomide, or Bortezomib, Compared to“standard Chemotherapy”, as “salvage” Before Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC-AT), for Relapsed Multiple Myeloma

Ciclosporine and Metotrexate Reduce the Risk of High Grade Acute Gvhd after Busulfan, Fludarabine and Anti-Thymocyte Globulin conditioning Regimen in Comparison with Cyclosporine Alone

Updated Analysis of Allogeneic HSCT after RIC for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Outcome of Treatment after First Relapse in Adults Patients with Acute Lymphoblastic Leukemia (ALL) Initially Treated by the LALA-94 Trial.

Allogeneic Stem Cell Transplantation with Reduced Intensity Conditionning Regimen (RIC) for Adult Patients with AML: Same Results in Secondary and De Novo AML.

Updated Analysis of Hematopoietic Stem Cell Transplantations after Reduced Intensity Conditioning Regimen (RIC HSCT) for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Low Progression-Free Survival for High-Risk Patients Treated with Reduced-Intensity Conditioning Regimen Allogeneic Stem Cell Transplantations with Volunteer Unrelated Donors.

Impact of Hematopoietic Stem Cell (HSC) Recruitment and Graft Composition on Transplant Outcome after Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Study of the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Usefulness of Recombinant Human Erythropoietin during Induction-Consolidation Chemotherapy for Chronic Hematological Lymphoid Malignancies: Improving Stem Cell Harvest and Reducing Blood-Product Support for Patients Receiving Autologous Stem-Cell Transplantation.

Dendritic Cells Recovery and Chimerism after Reduced Intensity Hematopoietic Stem Cell Transplantation.

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free Survival in Mantle Cell Lymphoma - Long Term Follow up of a Prospective Randomized Trial of the European MCL Network .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only